Trial Profile
B-type Natriuretic Peptide for Cardio-Renal Decompensation Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Apr 2015
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Decompensated heart failure
- Focus Pharmacodynamics
- Acronyms BNP-CARDS
- 06 Nov 2007 Results have been published.
- 19 Apr 2007 New trial record.